Midgard Science

Avenue Biosciences

Menlo Park, CA, United States avenuebiosciences.com From their website, Nov 2026

Work here? Claim this listing

About

Avenue Biosciences develops protein engineering technology focused on optimizing the secretory pathway and signal peptides to improve protein yield and quality. It serves developers of biologics, including antibodies, fusion proteins, cell and gene therapies, mRNA therapies, enzymes, and AI-designed proteins. The company is based in Helsinki, Finland and Menlo Park, California.

Services

  • High-throughput signal peptide screening

    Screens multi-thousand signal peptide libraries customized for a target protein to identify the best-performing signal peptide.

  • Single-chain signal peptide screening

    Single-chain signal peptide screening across large libraries of variants for therapeutic proteins.

  • Two-chain signal peptide screening

    Optimizes two different chains in combination for balanced assembly, built for formats such as antibodies.

  • Custom signal peptide screening

    Designs bespoke screens for complex targets such as 3-chain or membrane proteins.

  • Secretory pathway optimization

    Engineers secretion to improve production yield and product quality in biologics development.

  • Single-chain screening

    Screens signal peptide variants for single-chain therapeutic proteins.

  • Two-chain screening

    Optimizes two chains in combination for balanced assembly, built for formats such as antibodies.

  • Custom screening

    Designs bespoke screens for complex targets such as three-chain or membrane proteins.

2 more services
  • Screening in CHO cells
  • DNA analysis
What to send
  • Target protein sequence
  • Organization contact form submission
  • Client objectives for the screen

Capabilities

Assays and studies
  • Peptides
  • Antibodies
  • CHO
  • mRNA
  • NGS
  • HTS
12 more
  • High-throughput screening
  • Secretion efficiency assay
  • NGS analysis
  • Mass spectrometry
  • SEC-MALS
  • Assembly analysis
  • Quality analysis
  • Signal peptide screening
  • Single-cell secretion assay
  • Secretion titer analysis
  • Intact-mass analysis
  • Cleavage confirmation by mass spectrometry
Scale and capacity
  • Milliliter to liter volume
  • Multi-thousand signal peptide library
  • Thousands of signal peptide variants
Therapeutic areas
  • Biologics
  • Protein therapeutics
  • Vaccine development
  • Cancer
  • Infectious diseases
  • Immunology
  • Rare diseases

Instruments and platforms

  • SEC-MALS
  • Mass spectrometry
  • NGS

Modalities and species

Modalities
  • Antibody
  • Bispecific
  • Peptide
  • mRNA
  • Cell therapy
  • Recombinant protein
  • Biosimilar
Species and models
  • CHO cells
  • Mammalian protein production system

Industries served

  • Biotechnology
  • Life sciences

Details

Founded
2024
Based in
Menlo Park, CA, United States
Sites
  • Helsinki, Finland
  • Palo Alto, United States
Serves
Europe, United States, USA

Similar labs